The Minister of Health, Carolina Darias, made a call for calm this Saturday to people who have received the first dose of the AstraZeneca vaccine and stated that experts are assessing different options regarding what procedure to follow with the second dose.
This is what she stated this Saturday after visiting the Insular University Hospital of Gran Canaria to see the vaccination point in the hospital complex, where she added that the decision made by the Government "will always come hand in hand with scientific evidence."
"The decisions we have made and those we are going to continue making come from the hand of expert people who know and can advise us to improve decisions," she observed while clarifying that there is still time to make the best decision.
Darias explained that there are different scenarios on this issue: one is to stay with the first dose, since it establishes a protection percentage of 70%; and another is to administer a second dose in due time with another RNA-type vaccine, something that other countries such as Germany or France have already adopted.
"But in any case --she continued--, we will announce the decision we adopt with the help of the experts who are analyzing the case, and therefore, we must ask for tranquility. The people involved are going to have a safe response and in accordance with the circumstances of the vaccine's own methodology in question."
Here, the minister especially emphasized that all vaccines are safe, effective and save lives, understanding that what is being done is maximizing the virtues of each vaccine to direct them to the groups that may be most benefited.
Hand in hand with Europe with Janssen vaccines
Regarding the Janssen vaccine, Darias explained that the Government of Spain is hand in hand with the European Medicines Agency and that we must see what the agency itself says about it.
"These vaccines will arrive first thing on Tuesday and in principle they will be applied in accordance with the latest update of the vaccination strategy in the same typology as the RNA vaccines; that is, we will converge from 80 years down", she pointed out.
